We speculated that immune Mks migrate to lung and cardiac tissues in large amount especially in severe COVID-19 patients and that COVID-19 platelets may be generated from immune Mks, expressing higher levels of PRMT1 in the lungs, which lead to severe thrombosis. This evidence concerns the gene PRMT1 and COVID-19.